Insider · CIK 0002076008
Lisa Marie Nettis
Files at NEPH (NEPHROS INC). First filing -, latest -.
In brief
Lisa Marie Nettis files SEC Form 4 as director at NEPH (NEPHROS INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Lisa Marie Nettis has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 10, 2025 | NEPH NEPHROS INC | AGrant or award Common Stock | +1,622 | $0.00 | $0 | 1,622 | Nov 13, 2025 |
| Aug 11, 2025 | NEPH NEPHROS INC | AGrant or award Stock Option (right to buy)derivative | +13,229 | $0.00 | $0 | 13,229 | Aug 13, 2025 |
Questions about Lisa Marie Nettis
Answered from the filings on this page, as of the latest one.
Is Lisa Marie Nettis buying or selling?
Lisa Marie Nettis has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Lisa Marie Nettis's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Lisa Marie Nettis has 0.
Where does Lisa Marie Nettis file Form 4?
Lisa Marie Nettis has filed Form 4 at NEPH (NEPHROS INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.